Who owns the LENTI-G trademark?

The LENTI-G trademark is owned by Genetix Biotherapeutics, Inc..

What class is the LENTI-G trademark registered in?

The LENTI-G trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LENTI-G?

The USPTO serial number for LENTI-G is 79231837.

What is the registration number for LENTI-G?

LENTI-G is registered under USPTO registration number 5603938.

Sealvo

Home Search: LENTI-GLENTI-G #79231837

Back

Updated Sep 27, 2026·42 searches this week

View on USPTO TSDR Find similar marks

LEN

USPTO Trademark Record

ABANDONED

LENTI-G

SN 79231837·Reg 5603938·Filed Mar 15, 2018

Owner Genetix Biotherapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LENTI-G (Serial No. 79231837), Registration No. 5603938, is a abandoned US trademark filed on Mar 15, 2018 by Genetix Biotherapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Conflict Analysis

Full conflict analysis for LENTI-G (SN 79231837) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

LENTI-G (Reg. #5603938) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Mar 15, 2018

SERIAL

79231837

REG#

5603938

REGISTERED

Nov 13, 2018

Filing Information

StatusABANDONED

Filing DateMar 15, 2018

Serial Number79231837

Registration No.5603938

Registration DateNov 13, 2018

Status DateMay 30, 2025

Published for OppositionAug 28, 2018

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

37 events

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Jan 30, 2026

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 18, 2025

CHANGE OF NAME/ADDRESS REC'D FROM IB

NEW REPRESENTATIVE AT IB RECEIVED

Nov 13, 2025

NEW REPRESENTATIVE AT IB RECEIVED

CANCELLED SECTION 71

May 30, 2025

CANCELLED SECTION 71

NEW REPRESENTATIVE AT IB RECEIVED

Sep 13, 2024

NEW REPRESENTATIVE AT IB RECEIVED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Dec 23, 2023

CHANGE OF NAME/ADDRESS REC'D FROM IB

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Nov 13, 2023

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Aug 26, 2022

CHANGE OF NAME/ADDRESS REC'D FROM IB

NEW REPRESENTATIVE AT IB RECEIVED

Nov 15, 2019

NEW REPRESENTATIVE AT IB RECEIVED

Oct 18, 2019

NEW REPRESENTATIVE AT IB RECEIVED

CHANGE OF OWNER RECEIVED FROM IB

Jun 13, 2019

CHANGE OF OWNER RECEIVED FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Mar 16, 2019

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Feb 25, 2019

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Feb 25, 2019

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Feb 13, 2019

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Nov 13, 2018

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Aug 28, 2018

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 28, 2018

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Aug 24, 2018

NOTIFICATION PROCESSED BY IB

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Aug 08, 2018

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 08, 2018

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Aug 08, 2018

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

REFUSAL PROCESSED BY IB

Jul 27, 2018

REFUSAL PROCESSED BY IB

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 19, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 19, 2018

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jul 18, 2018

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jul 18, 2018

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 18, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 18, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

REFUSAL PROCESSED BY MPU

Jul 11, 2018

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 11, 2018

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jun 27, 2018

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jun 26, 2018

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Jun 25, 2018

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

May 22, 2018

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 16, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

May 10, 2018

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Genetix Biotherapeutics, Inc.

Additional USPTO filings from the same owner.

LYF

LYFGENIA

98299529

GENETIX BIOTHERAPEUTICS INC.

REGISTERED

LYF

LYFGENIA

98299543

GENETIX BIOTHERAPEUTICS INC.

REGISTERED

LYF

LYFGENIA

98299561

GENETIX BIOTHERAPEUTICS INC.

REGISTERED

ZYN

ZYNTEGLO

79254523

Genetix Biotherapeutics, Inc.

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

LEN

LENTI-D

79232103

Genetix Biotherapeutics, Inc.

REGISTERED

79436484

Nanjing GenScript Biotech Co., Ltd.

REGISTERED

98458591

Garnuu Inc.

REGISTERED

99535395

Fang Wen

REGISTERED

LENTI-G

Run a conflict check

Other Marks by Genetix Biotherapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company